Iffeldorf, Germany

Sabine Nussbaum

This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sabine Nussbaum: Innovator in Immunological Processes

Introduction

Sabine Nussbaum is a prominent inventor based in Iffeldorf, Germany. She has made significant contributions to the field of immunology, particularly in the detection of analytes in samples. Her innovative work has led to the development of a patented process that enhances the accuracy of immunoassays.

Latest Patents

Nussbaum holds a patent for the "Reduction of interference of immunoassays by substances derived from the framework regions of antibodies." This invention focuses on an immunological process for detecting tumor markers in samples. It involves adding substances containing peptide sequences derived from the framework regions of variable domains of antibodies to reduce interference in the testing process. This advancement is crucial for improving the reliability of immunoassays.

Career Highlights

Sabine Nussbaum is associated with Roche Diagnostics GmbH, a leading company in the field of diagnostics. Her work at Roche has allowed her to contribute to groundbreaking research and development in immunological testing. Nussbaum's expertise and innovative mindset have positioned her as a key figure in her field.

Collaborations

Throughout her career, Nussbaum has collaborated with notable colleagues, including Ellen Moessner and Helmut Lenz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Sabine Nussbaum's contributions to immunology through her patented inventions demonstrate her commitment to advancing medical diagnostics. Her work continues to impact the field positively, enhancing the accuracy of immunoassays and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…